J3M-MC-JZQB: Revenus, téléchargements et mots-clés

Name: J3M-MC-JZQB
Author: Medable, Inc.

J3M-MC-JZQB

Par Medable, Inc. sur AppTrack Ninja.

A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.

Catégories: Health & Fitness

Classements App Store, captures, estimations et apps similaires pour J3M-MC-JZQB.

Loading…

apptrack.ninjaApp Store intelligence

Privacy Terms Pricing Refunds Contact Compare Features

This page may contain: (i) copyrighted material and trademarks belonging to third parties that are made available for commentary and research purposes only, which constitute fair uses as provided for under applicable copyright laws. All third-party product, service, and company names and logos are trademarks belonging to their respective owners. Their use constitutes nominative fair use under applicable trademark laws and does not imply any affiliation with or endorsement by the respective owners; and (ii) estimates (including market estimates) which are generated through proprietary methodologies using a variety of sources. Such estimates are provided "as is" and "as available" for informational purposes only, and AppTrack Ninja disclaims all representations, warranties, and liability as to their accuracy, completeness, currency, provenance, rights, or other attributes. Any reliance you place on them is at your sole risk. AppTrack Ninja is not registered in any investment advisor capacity and does not offer any financial, investment, or business advice. The estimates or anything else we provide should never be construed as an offer, recommendation, or solicitation to buy or sell any security or investment, or to make any investment decisions.

Loading…

apptrack.ninjaApp Store intelligence

Privacy Terms Pricing Refunds Contact Compare Features

This page may contain: (i) copyrighted material and trademarks belonging to third parties that are made available for commentary and research purposes only, which constitute fair uses as provided for under applicable copyright laws. All third-party product, service, and company names and logos are trademarks belonging to their respective owners. Their use constitutes nominative fair use under applicable trademark laws and does not imply any affiliation with or endorsement by the respective owners; and (ii) estimates (including market estimates) which are generated through proprietary methodologies using a variety of sources. Such estimates are provided "as is" and "as available" for informational purposes only, and AppTrack Ninja disclaims all representations, warranties, and liability as to their accuracy, completeness, currency, provenance, rights, or other attributes. Any reliance you place on them is at your sole risk. AppTrack Ninja is not registered in any investment advisor capacity and does not offer any financial, investment, or business advice. The estimates or anything else we provide should never be construed as an offer, recommendation, or solicitation to buy or sell any security or investment, or to make any investment decisions.